SEX-RELATED DIFFERENCES IN THE LEVELS OF URINE 6-SULFATOXYMELATONIN IN VERY LOW BIRTH WEIGHT INFANTS
Affiliation:
1. Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine
Abstract
Background. The sex-related differences of the urinary 6-sulfatoxymelatonin have not been studied in premature infants yet. The purpose of the work was to measure the daily urinary 6-sulfatoxymelatonin in premature infants with a very low birth weight.
Materials and Methods. Fifty premature infants (28 males and 22 females) with gestational age less than 33 weeks and body weight from 999 g to 1499 g were involved in the study. Urine 6-sulfatoxymelatonin was assessed using urine collection on the 1st day and on the 10th‒14th days of life.
Results. The level of urine 6-sulfatoxymelatonin on the 1st day of life showed a significant increase in its excretion in females compared to males. The median values in males were 202.0 (95% CI 77.1–390.9) pg/ml and in females 437.0 (279.6–501.0) pg/ml, p=0.0103. Its level on the 10th–14th days of life significantly decreased both in males 57.0 (95 % СІ 45,0–99.7) pg/ml, p=0.0028 and in females 90.0 (51.9–160.7) pg/ml, p=0.0021 without differences in sex-related distribution, p=0.3940.
Conclusions. The melatonin metabolite as urinary 6-sulfatoxymelatonin in premature infants with a very low birth weight demonstrates sex-related differences with significant increase in females compared to males on the 1st day of life and no sex-related difference on the 10th–14th days of life. The trend of reduced pineal function is a key point in understanding the neuroendocrine reactivity in male preterms. Future investigation of sex-related aspects of urinary 6-sulfatoxymelatonin excretion in children, especially premature infants, is required.
Publisher
Kharkiv National Medical University
Reference18 articles.
1. Batllori, M., Molero-Luis, M., Arrabal, L., Heras, J. L., Fernandez-Ramos, J. A., Gutiérrez-Solana, L. G., … & Artuch, R. (2017). Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient pa-tients. Scientific reports, 7(1), 14675. https://doi.org/10.1038/s41598-017-15063-8 2. Gunn, P. J., Middleton, B., Davies, S. K., Revell, V. L., & Skene, D. J. (2016). Sex differences in the circa-dian profiles of melatonin and cortisol in plasma and urine matrices under constant routine conditions. Chronobiology international, 33(1), 39–50. https://doi.org/10.3109/07420528.2015.1112396 3. Nathan, P. J., Wyndham, E. L., Burrows, G. D., & Norman, T. R. (2000). The effect of gender on the mela-tonin suppression by light: a dose response relationship. Journal of neural transmission (Vienna, Austria: 1996), 107(3), 271–279. https://doi.org/10.1007/s007020050022 4. Reiter, R. J., Mayo, J. C., Tan, D. X., Sainz, R. M., Alatorre-Jimenez, M., & Qin, L. (2016). Melatonin as an antioxidant: under promises but over delivers. Journal of pineal research, 61(3), 253–278. https://doi.org/10.1111/ jpi.12360 5. Bagci, S., Horoz, Ö. Ö., Yildizdas, D., Reinsberg, J., Bartmann, P., & Müller, A. (2012). Melatonin status in pediatric intensive care patients with sepsis. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 13(2), e120–e123. https://doi.org/10.1097/PCC.0b013e3182191dc4
|
|